NCT05027074 · Interventional trial
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
Overall registry status Completed
Phase 2
Conditions End-Stage Kidney Disease, End-Stage Renal Disease, Kidney Failure, Chronic
Delaware Valley sites
- Elixia at Clinical Renal Associates ( Site 0677) · Upland, PA · Delaware County
First posted
Registry updated
Added to the directory